This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kuppen, P. J. K. Articles by Schrier, P. I. Search for Related Content PubMed PubMed Citation Articles by Kuppen, P. J. K. Articles by Schrier, P. I.

cis-Diamminedichloroplatinum(II)-resistant Sublines Derived from Two Human Ovarian Tumor Cell Lines¹

Department of Clinical Oncology, Leiden University Hospital, Leiden, The Netherlands

In two human ovarian tumor cell lines, resistance to cis-diamminedichloroplatinum(II) (CDDP) was induced by continuous exposure of the parental lines to an increasing CDDP concentration in the culture medium. In contrast, a six times repeated pulse exposure of 6.7 µM or 16.7 µM CDDP for 1 h did not result in a cell line that showed a higher survival in CDDP-containing medium. The ID₅₀ value for CDDP was seven to eight times higher for the resistant lines and those lines were able to grow at 3.3 µM CDDP. The induced resistance was stable during at least 25 doubling times. The CDDP-resistant sublines showed cross-resistance to the CDDP-analogues cis-diammine-1,1-cyclobutane-dicarboxylateplatinum(II) and cis-dichlorobis(isopropylamine)-trans-dihydroxyplatinum(IV) indicating that resistance to the different platinum compounds is generated by a common mechanism. The resistant sublines were also cross-resistant to mitomycin C and melphalan. The degree of cross-resistance for the tested drugs varied widely between the two cell lines. Resistance to CDDP was clearly correlated to decreased amounts of platinum in the resistant cells as compared to the sensitive cells. The amplification and expression of genes encoding proteins that had been shown to be involved in multidrug resistance, e.g., the M_r 170,000 P-glycoprotein was also studied. No amplification or overexpression of these genes could be shown in the resistant cell lines.

¹ This work was supported by a grant from the Koningin Wilhemina Fonds (Netherlands Cancer Foundation).

² Present address: Department of Oncology, Antwerp University Hospital, Antwerp, Belgium.

³ To whom requests for reprints should be addressed, at Department of Clinical Oncology, Leiden University Hospital, Building, I, K-1/P-51, P. O. Box 9600, 2300 RC Leiden, The Netherlands.

Received 3/11/87. Revised 10/ 8/87. Accepted 2/25/88.

This article has been cited by other articles:

				G. Li, H. Alexander, N. Schneider, and S. Alexander Molecular basis for resistance to the anticancer drug cisplatin in Dictyostelium Microbiology, September 1, 2000; 146(9): 2219 - 2227. [Abstract] [Full Text] [PDF]

				P. Frit, Y. Canitrot, C. Muller, N. Foray, P. Calsou, E. Marangoni, J. Bourhis, and B. Salles Cross-Resistance to Ionizing Radiation in a Murine Leukemic Cell Line Resistant to cis-Dichlorodiammineplatinum(II): Role of Ku Autoantigen Mol. Pharmacol., July 1, 1999; 56(1): 141 - 146. [Abstract] [Full Text]